Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386093238> ?p ?o ?g. }
Showing items 1 to 68 of
68
with 100 items per page.
- W4386093238 abstract "Abstract Background Hepatocellular carcinoma is a highly prevalent tumor globally and the world's second leading cause of cancer-related deaths. Glypican-3, a heparan sulfate proteoglycan expressed on the surface of HCC cells, has emerged as a new molecule with a strong link to occurrence and progression of HCC. This study was done to determine the role of Glypican-3 in diagnosis of HCC and its prognostic value following different treatment modalities. The study included thirty patients with liver cirrhosis and HCC on top, and thirty patients with liver cirrhosis without HCC, standard laboratory investigations, abdominal ultrasound and triphasic computed tomography were done for all patients. serum Alpha fetoprotein and Glypican-3 were measured in all patients before and one month after different treatment modalities Results Glypican-3 was significantly higher in HCC group (2.28 ± 0.97) in comparison to cirrhosis group (0.56 ± 0.31) with P-value 0.000. Glypican-3 level was higher in larger sized lesions with p value 0.023, one month after treatment with different modalities, Glypican-3 declined significantly (from 2.28 ± 0.97 to 1.44 ± 0.93) with p value 0.000. At a Cut-off point of > 1.1 ng/ml Glypican-3 has 93.3% sensitivity, 96.67% specificity, 96.6% PPV and 93.5% NPV for detection of HCC. Conclusion Glypican-3 can be a valuable diagnostic marker for HCC diagnosis and prognosis after various treatment modalities. And may be complementary to Alpha fetoprotein increasing overall sensitivity of HCC detection." @default.
- W4386093238 created "2023-08-24" @default.
- W4386093238 creator A5015319684 @default.
- W4386093238 creator A5065868201 @default.
- W4386093238 creator A5079873227 @default.
- W4386093238 creator A5080520851 @default.
- W4386093238 date "2023-06-01" @default.
- W4386093238 modified "2023-10-16" @default.
- W4386093238 title "Value of Glypican-3 as a Diagnostic and Prognostic Biomarker for Hepatocellular Carcinoma before and after Treatment. A Prospective Study" @default.
- W4386093238 doi "https://doi.org/10.1093/qjmed/hcad069.376" @default.
- W4386093238 hasPublicationYear "2023" @default.
- W4386093238 type Work @default.
- W4386093238 citedByCount "0" @default.
- W4386093238 crossrefType "journal-article" @default.
- W4386093238 hasAuthorship W4386093238A5015319684 @default.
- W4386093238 hasAuthorship W4386093238A5065868201 @default.
- W4386093238 hasAuthorship W4386093238A5079873227 @default.
- W4386093238 hasAuthorship W4386093238A5080520851 @default.
- W4386093238 hasConcept C121608353 @default.
- W4386093238 hasConcept C126322002 @default.
- W4386093238 hasConcept C143998085 @default.
- W4386093238 hasConcept C144024400 @default.
- W4386093238 hasConcept C188816634 @default.
- W4386093238 hasConcept C2776231280 @default.
- W4386093238 hasConcept C2777214474 @default.
- W4386093238 hasConcept C2778019345 @default.
- W4386093238 hasConcept C2779742787 @default.
- W4386093238 hasConcept C2779903281 @default.
- W4386093238 hasConcept C2781197716 @default.
- W4386093238 hasConcept C36289849 @default.
- W4386093238 hasConcept C55493867 @default.
- W4386093238 hasConcept C71924100 @default.
- W4386093238 hasConcept C86803240 @default.
- W4386093238 hasConcept C90924648 @default.
- W4386093238 hasConceptScore W4386093238C121608353 @default.
- W4386093238 hasConceptScore W4386093238C126322002 @default.
- W4386093238 hasConceptScore W4386093238C143998085 @default.
- W4386093238 hasConceptScore W4386093238C144024400 @default.
- W4386093238 hasConceptScore W4386093238C188816634 @default.
- W4386093238 hasConceptScore W4386093238C2776231280 @default.
- W4386093238 hasConceptScore W4386093238C2777214474 @default.
- W4386093238 hasConceptScore W4386093238C2778019345 @default.
- W4386093238 hasConceptScore W4386093238C2779742787 @default.
- W4386093238 hasConceptScore W4386093238C2779903281 @default.
- W4386093238 hasConceptScore W4386093238C2781197716 @default.
- W4386093238 hasConceptScore W4386093238C36289849 @default.
- W4386093238 hasConceptScore W4386093238C55493867 @default.
- W4386093238 hasConceptScore W4386093238C71924100 @default.
- W4386093238 hasConceptScore W4386093238C86803240 @default.
- W4386093238 hasConceptScore W4386093238C90924648 @default.
- W4386093238 hasIssue "Supplement_1" @default.
- W4386093238 hasLocation W43860932381 @default.
- W4386093238 hasOpenAccess W4386093238 @default.
- W4386093238 hasPrimaryLocation W43860932381 @default.
- W4386093238 hasRelatedWork W1995827984 @default.
- W4386093238 hasRelatedWork W2266860383 @default.
- W4386093238 hasRelatedWork W2531151695 @default.
- W4386093238 hasRelatedWork W2569732664 @default.
- W4386093238 hasRelatedWork W2803171320 @default.
- W4386093238 hasRelatedWork W2979107195 @default.
- W4386093238 hasRelatedWork W3030449887 @default.
- W4386093238 hasRelatedWork W3032621101 @default.
- W4386093238 hasRelatedWork W3095032159 @default.
- W4386093238 hasRelatedWork W325818975 @default.
- W4386093238 hasVolume "116" @default.
- W4386093238 isParatext "false" @default.
- W4386093238 isRetracted "false" @default.
- W4386093238 workType "article" @default.